Great news in Vagus Nerve world for you guys:
RESET-RA trial: Vagus nerve stimulation reduces rheumatoid arthritis severity.
A double-blind study of 242 patients.
Active group received cervical vagus nerve stimulation via implanted device for 12 weeks.
Device activates cholinergic anti-inflammatory pathway (CAP).
Acetylcholine release suppresses cytokine production (TNF-α, IL-1β, IL-6).
DAS28-CRP score reduced by 1.9 points in active group vs. 0.7 in sham (p<0.0001).
CRP, ESR, TNF-α also significantly declined.
52% achieved ACR50 in active group vs. 22% in sham.
Comparable mild adverse events observed.
Vagus nerve stimulation targets inflammation, validating CAP for rheumatoid arthritis treatment.